10 Sep 17

Cardium announced that sufferers enrolled for MATRIX clinical trail have completed their evaluation period Cardium Therapeutics today announced that all sufferers enrolled in the Company’s MATRIX clinical study have now completed their initial 12-week evaluation period and that it plans to provide detailed safety and efficacy data in late September 2009 comprim├ęs mous . The Stage 2b MATRIX scientific trial is a potential, randomized, double-blind, placebo-controlled research of Excellarate for the potential treatment of persistent diabetic foot ulcers.


CareRise allowed U.S. Patent for its 24/7 Staffing Census software program A new software program produced by CareRise will decrease the time it takes for inpatient health care facilities to compute their staffing needs as it relates to the patient population. 24/7 Staffing Census allows inpatient health care facilities to calculate their mandatory nurse-to-patient staffing needs, adhere to their state’s patient-per-day time ratios and get a daily report concerning how exactly it affects their bottom line. CareRise, a innovator in risk administration in the healthcare sector, provides been allowed a USA patent on its 24/7 Staffing Census computer software to obtain real-period synchronization of staffing must comply with mandatory PPD ratios.